$465 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 18 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QDEL | Sell | QUIDEL CORP | $105,902,000 | -15.0% | 1,785,264 | -6.2% | 22.78% | -14.1% |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $99,674,000 | +9.0% | 4,356,363 | +0.2% | 21.44% | +10.2% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $99,451,000 | -8.3% | 5,128,970 | -1.9% | 21.39% | -7.3% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $73,258,000 | +39.4% | 1,672,950 | +63.8% | 15.76% | +40.9% |
| DERM | Buy | DERMIRA INC | $16,826,000 | -9.2% | 1,760,072 | +28.7% | 3.62% | -8.2% |
| MOTS | Buy | MOTUS GI HLDGS INC | $11,413,000 | +5.5% | 3,766,666 | +35.7% | 2.46% | +6.6% |
| SLNO | SOLENO THERAPEUTICS INC | $10,678,000 | +35.9% | 3,813,558 | 0.0% | 2.30% | +37.4% | |
| OPK | OPKO HEALTH INC | $8,994,000 | -6.5% | 3,686,194 | 0.0% | 1.94% | -5.5% | |
| VRML | VERMILLION INC | $8,745,000 | -22.6% | 9,825,289 | 0.0% | 1.88% | -21.8% | |
| BIOL | Sell | BIOLASE INC | $7,605,000 | -48.2% | 5,173,250 | -16.2% | 1.64% | -47.7% |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $6,720,000 | -16.3% | 1,110,666 | 0.0% | 1.45% | -15.4% | |
| CI | New | CIGNA CORP NEW | $4,672,000 | – | 29,653 | +100.0% | 1.00% | – |
| AGEN | Buy | AGENUS INC | $4,227,000 | +4.7% | 1,408,918 | +3.7% | 0.91% | +5.8% |
| CFRX | Buy | CONTRAFECT CORP | $3,242,000 | +45.0% | 6,356,649 | +13.1% | 0.70% | +46.4% |
| BIIB | BIOGEN INC | $1,489,000 | -1.1% | 6,368 | 0.0% | 0.32% | 0.0% | |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INCcall | $808,000 | +114.3% | 180,000 | -12.8% | 0.17% | +117.5% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO Lcall | $692,000 | -79.7% | 458,800 | -37.9% | 0.15% | -79.5% |
| AMRN | Buy | AMARIN CORP PLCcall | $478,000 | +16.6% | 650,700 | +293.4% | 0.10% | +18.4% |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF INcall | $0 | – | -500,000 | -100.0% | -0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.